Ardsley Advisory Partners’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-18,335,767
| Closed | -$21.3M | – | 163 |
|
|
2022
Q2 | $21.3M | Hold |
18,335,767
| – | – | 3.5% | 5 |
|
|
2022
Q1 | $19.8M | Hold |
18,335,767
| – | – | 3.3% | 5 |
|
|
2021
Q4 | $13.2M | Buy |
18,335,767
+1,643,014
| +10% | +$1.33M | 2.52% | 12 |
|
|
2021
Q3 | $12M | Hold |
16,692,753
| – | – | 1.83% | 14 |
|
|
2021
Q2 | $22.2M | Hold |
16,692,753
| – | – | 2.61% | 11 |
|
|
2021
Q1 | $27.9M | Buy |
16,692,753
+741,617
| +5% | +$1.54M | 3.39% | 5 |
|
|
2020
Q4 | $18.4M | Buy |
15,951,136
+1,648,037
| +12% | +$1.97M | 3.03% | 9 |
|
|
2020
Q3 | $15.6M | Buy |
14,303,099
+343,341
| +2% | +$417K | 3.02% | 8 |
|
|
2020
Q2 | $14.7M | Buy |
13,959,758
+429,176
| +3% | +$397K | 3.12% | 9 |
|
|
2020
Q1 | $9.96M | Buy |
13,530,582
+874,314
| +7% | +$927K | 3.9% | 7 |
|
|
2019
Q4 | $11.4M | Buy |
12,656,268
+874,326
| +7% | +$1.06M | 1.82% | 17 |
|
|
2019
Q3 | $14.7M | Buy |
11,781,942
+1,457,195
| +14% | +$2.06M | 3.3% | 8 |
|
|
2019
Q2 | $13.5M | Hold |
10,324,747
| – | – | 2.13% | 16 |
|
|
2019
Q1 | $13.7M | Buy |
10,324,747
+1,500
| +0% | +$2.29K | 2.63% | 13 |
|
|
2018
Q4 | $13.2M | Hold |
10,323,247
| – | – | 3.32% | 10 |
|
|
2018
Q3 | $16.4M | Sell |
10,323,247
-25,000
| -0.2% | -$48.5K | 2.21% | 16 |
|
|
2018
Q2 | $13.4M | Hold |
10,348,247
| – | – | 2.02% | 19 |
|
|
2018
Q1 | $12.7M | Buy |
10,348,247
+6,666,667
| +181% | +$8.94M | 1.91% | 19 |
|
|
2017
Q4 | $4.05M | Hold |
3,681,580
| – | – | 0.49% | 47 |
|
|
2017
Q3 | $4.23M | Hold |
3,681,580
| – | – | 0.56% | 52 |
|
|
2017
Q2 | $4.53M | Buy |
3,681,580
+2,907,142
| +375% | +$4.12M | 0.71% | 48 |
|
|
2017
Q1 | $1.51M | Hold |
774,438
| – | – | 0.23% | 75 |
|
|
2016
Q4 | $1.66M | Hold |
774,438
| – | – | 0.27% | 65 |
|
|
2016
Q3 | $1.32M | Buy |
774,438
+246,712
| +47% | +$300K | 0.21% | 74 |
|
|
2016
Q2 | $433K | Buy |
+527,726
| New | +$409K | 0.08% | 91 |
|
|
2014
Q3 | – | Sell |
-97,500
| Closed | -$1.13M | – | 269 |
|
|
2014
Q2 | $1.13M | Buy |
97,500
+44,700
| +85% | +$507K | 0.14% | 87 |
|
|
2014
Q1 | $738K | Buy |
52,800
+2,800
| +6% | +$44K | 0.11% | 98 |
|
|
2013
Q4 | $889K | Hold |
50,000
| – | – | 0.12% | 71 |
|
|
2013
Q3 | $843K | Buy |
+50,000
| New | +$702K | 0.17% | 72 |
|
Ardsley Advisory Partners's MBII Position: Q3 2022 in Review
Ardsley Advisory Partners sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 18,335,767 shares — an estimated $21.3M sold.
Ardsley Advisory Partners first reported a position in MBII in Q3 2013 and held it in 29 quarters. The position peaked at $27.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- Ardsley Advisory Partners reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- Ardsley Advisory Partners sold 18,335,767 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $21.3M.
- Ardsley Advisory Partners first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 29 quarters.
- Ardsley Advisory Partners's Marrone Bio Innovations, Inc. position peaked at $27.9M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on Ardsley Advisory Partners's 13F filing for Q3 2022, filed 14 Nov 2022.